large

Antischizophrenic and central nervous system depressant effects of methanol leaf extract of Cassia Singueana (fransen) in wistar rats and mice

Yusuf Ibrahim Alkali1*, Abdulgafar O. Jimoh2, Kabiru Abubakar1, Yerima Musa1

1Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria, 2Department of Pharmacology and Therapeutics, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria

Address for correspondence: Yusuf Ibrahim Alkali, Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria. E-mail: galilie050@gmail.com

ABSTRACT

Cassia singueana, a medium-sized tree which is well distributed in Benin Republic, Cameroon, Chad, Gambia, and Nigeria, is reported to have wide ethnomedicinal applications notably in fever, abdominal pain, hernia, heartburn constipation, and snakebite. This study evaluated the antischizophrenic and central nervous system depressant effect of its methanol leaf extract in mice and rats using apomorphine-induced stereotypic climbing, catalepsy test, hole-board test, beam walking assay of motor coordination deficit, and diazepam-induced sleep. Preliminary phytochemical screening revealed the presence of carbohydrate, saponins, cardiac glycoside, tannins, alkaloids, phenols, steroids, anthraquinones, and proteins. The oral median lethal dose 50% of methanol leaf extract of C. singueana was found to be 2154 mg/kg. The methanol leaf extract of C. singueana significantly (P < 0.05) and dose dependently (200, 400, and 800 mg/kg) decreased the onset and increased the duration of diazepam-induced sleep in mice. The extract also causes significant (P < 0.05) decrease in a number of head dip of mice in hole-board test. The methanol leaf extract of C. singueana significantly (P < 0.05) increased the number of the foot slip of mice in beam walk assay of motor coordination deficit. For antischizophrenic studies, the methanol leaf extract of C. singueana significantly (P < 0.05) decreased the number of climbing by mice in apomorphine-induced stereotypic climbing behavior model, also the methanol leaf extract of C. singueana significantly (P < 0.05) increased the duration of haloperidol-induced catalepsy in glass bar test. It may be concluded that the methanol leaf extract of C. singueana contains bioactive phytochemicals with antischizophrenic and central nervous system depressant activity.

Keywords: Antischizophrenia, Apomorphine, Cassia singueana, Central nervous system depressant


INTRODUCTION

The World Health Organization reported that approximately 450 million people suffer from mental or behavioral disorders without proper treatment.[1] The onset of schizophrenia typically occurs in early adulthood between 15 and 35 years of age.[2] These challenges reflect possible increase in global bioburden of diseases from 12.3% to 15% by 2020. Some studies comparing the second-generation antipsychotics with typical antipsychotics failed to substantiate any major therapeutic advantage of the former.[3] Available medications can be very beneficial, but for most affected individuals, apathy, lack of volition, and social withdrawal (the “negative” symptoms) may be resistant to treatment even though the medications alleviate the hallucinations and aggressive behaviors, the “positive” symptoms.[4]

Cassia singueana a small tree shrub 1–6 m high with spreading rounded open crown 2 m in diameter. Trunk to 15 cm across, with dark gray, rough bark irregularly longitudinally fissured; slash light brown, yellow within. Stems of branchlets faintly longitudinally ridged to teret, young apice densely pubescent with curled white hairs interspersed among minute ones forming an underlayer, becoming sparsely pubescent and glabrous as bark develops. Leaves: Petiole and rachis 4–30 cm long. Stipules subulate, A ± 5 mm long, 3 mm wide, caduceus; petiole 1.5–5 cm long including basal pulvinus, petiole gland lacking, rachis channeled, with stalked, fusiform to elliptic, deciduous gland between each pair of leaflets, sometimes excepting the terminal leaflet. The ethyl acetate and ethanol root bark extract of C. singueana show promising antioxidant properties both in vivo and in vitro.[5] The methanol root extract of C. singueana was also reported to have hepatoprotective and hypolipidemic effects in rats.[6] C. singueana methanol leaf possessed antiulcer effect.[7] It was also reported by Adamu et al.[8] that C. singueana has antifungal activity.

MATERIALS AND METHODS

Collection of Plant Material and Preparation of Extract

The plant was collected in Dange Shuni Local Government Area of Sokoto in January 2018, Sokoto State, Nigeria. The plant was identified and authenticated in the Department of Pharmacognosy and Ethnopharmacy, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University, Sokoto, and was deposited in the herbarium. The leaves of C. singueana were shade dried. The dried leaves were pulverize to powder using wooden pestle and mortar and then 500 g of the dried powder was weighed and subjected to cold maceration for 72 h with 95% methanol as the solvent of extraction, the mixture was allowed to stand for 5 h and was then shaken periodically. Whatman filter paper was used for filtration of the mixture and the extract was concentrated on water bath at 40°C. The dried extract was transferred to air tide container for storage.

DRUGS

Apomorphine (Ranbaxy Laboratories, India, MFD: 10/13. EPD: 12/19), Diazepam (Neon Pharmaceutical Pvt., Ltd., MFD: 07/14. EPD: 08/20), Haloperidol (RPG Science Pharmaceutical Pvt., Ltd., MFD: 10/14. EPD: 01/22), methanol, and distilled water were used.

ANIMALS AND TREATMENT

Wistar rats of both sexes weighing (90–120 g) and mice (18–20 g) were used in this study. The animals were maintained in a cage well ventilated with access to food and water ad libitum. All animal experimental protocols were conducted in compliance with human-animal care standards outlined in the National Institutes of Health Guide for Care and Use of Laboratory Animals.

Diazepam-induced Sleep

The method described by Beretz et al.[9] and modified by Rakotonirina et al.[10] was adopted. Briefly, 24 mice of either sex were assigned into four groups, each containing six mice. The first group received 10 ml/kg distilled water orally. The second, third, and fourth group received 200 mg/kg, 400 mg/kg, and 800 mg/kg orally of the C. singueana extract, respectively. 1 h post-treatment, all the mice were treated with diazepam 30 mg/kg orally, the animals were observed and onset and duration of sleep were recorded. Loss of righting reflex is considered as sleep onset and time interval between loss righting reflex and recovery to straightening were recorded as the duration of sleep.

Test for Exploratory Behavior in Mice (Hole-oard Test)

The method described by File[11] was adopted. Briefly, the apparatus includes white painted wooden board (60 cm × 30 cm) with 16 evenly spaced holes (1 cm diameter × 2 cm depth). 30 mice were randomly divided into five groups each containing six mice. The mice in the first group serve as the control which received 10 ml/kg distilled water orally. The mice in the second, third, and fourth group received 200, 400, and 800 mg/kg orally of the extract, respectively, while the mice in the fifth group received 1 mg diazepam per kg body weight orally. 1 h post-treatment, each mouse was placed at a corner of the board and the number of head dips in the hole was counted using a tally counter during 5 min.[12]

The Mice Beam Walking Assay for Motor Incoordination

The method previously described by Stanley et al.[13] was adopted for this study. Briefly, adult mice were trained to walk from a start platform along a ruler (80 cm long and 3 cm wide) elevated 30 cm above the bench by metal support to a goal box. Three trials were performed for each mouse and were designed such that the mouse tested would be aware that there was a goal box that could be reached. The mice that successfully walked along the ruler were randomly grouped into five groups each containing six mice. The first group received 10 ml/kg distilled water p.o. The second, third, and the fourth groups received 200, 400, and 800 mg/kg of the extract p.o, respectively. The fifth group received diazepam (1 mg/kg body weight, p.o).

Apomorphine-induced Stereotypic Climbing

The method described by Protais et al.[14] and modified by Costall and Naylor[15] was adopted for the study. Briefly, 24 adult mice were divided randomly into four groups each containing six mice. The first group received 10 ml/kg distilled water p.o. The second, third, and the fourth groups received 200, 400, and 800 mg//kg, respectively, p.o. 1 h post-treatment, all mice were treated with apomorphine (30 mg/kg body weight, subcutaneously). Each mouse was placed singly in a wire mesh stick cage and the climbing behavior was observed at 10, 20, and 30 min interval after apomorphine administration and scored as follows: 0 = four paws on the floor; 1 = fore feet holding the vertical bars; and 2 = four feet holding the vertical bars.

Catalepsy Test

The catalepsy procedure has been described previously.[16] Animals will first be examined in the crossed-leg position test and immediately thereafter in the bar test. In the crossed-leg position test, the hind limbs are placed over the ipsilateral forelimbs and the time during which an animal remained in this position was determined up to a maximum of 30 s. In the bar test, the forelimbs were placed on a horizontal, cylindrical metal bar (diameter 1.25 cm and height 10 cm), and the time during which both forelimbs remained on the bar was determined up to a maximum of 30 s. The bar test was repeated 3 and 6 min later and the mean of three trials was used for data analysis. Animals were returned to their cage between tests. Six animals were tested in each group. Positive control: Haloperidol, negative control: Distilled water, and test groups received 200, 400, and 800 mg/kg of the extract.

Data Analysis

Results were expressed as mean ± standard error of mean (SEM) and percentages. Data analysis was performed using SPSS statistical software (version 2.0). Comparison between groups was made using analysis of variance and Kruskal–Wallis test where necessary. When statistical difference was obtained, a post hoc Dunnett’s test was performed for multiple comparisons depending on nature of data. Values of P < 0.05 were considered statistically significant.

RESULTS

Effect of C. singueana Methanol Leaf Extract in Diazepam-induced Sleep in Mice

The methanol leaf extract of C. singueana significantly (P < 0.05) and dose dependently decreased the onset and increased the duration of sleep induced by diazepam [Figure 1].

thumblarge

Figure 1: Effect of methanol leaf extract of Cassia singueana on diazepam-induced sleep in mice. CSE: C. singueana methanol leaf extract. Data are presented as mean ± standard error of mean; *P < 0.05, n = 6, Dunnett’s post hoc test

Effect of Methanol Leaf Extract of C. singueana on Beam Walking Assay for Motor Coordination in Mice

C. singueana methanol leaf extract significantly (P < 0.05) increased the number of foot slip by mice in the beam walk assay; increased foot slip indicates motor coordination deficit [Figure 2].

thumblarge

Figure 2: Effect of methanol leaf extract of Cassia singueana on beam walking assay for motor coordination in mice. CSE: C. singueana methanol leaf extract. Data are presented as mean ± standard error of mean; *P < 0.05, n = 6, Dunnett’s post hoc test

Effect of Methanol Leaf Extract of C. singueana on Hole-board Test for Exploratory Behavior in Mice

C. singueana methanol leaf extract significantly (P < 0.05) and dose dependently decreased the number of head dips in the hole-board test, indicating decreased in exploratory behavior [Figure 3].

thumblarge

Figure 3: Effect of methanol leaf extract of Cassia singueana on hole-board test for exploratory behavior in mice. DZP: Diazepam, CSE: C. singueana methanol leaf extract. Data are presented as mean ± standard error of mean; *P < 0.05, n = 6, Dunnett’s post hoc test

Effect of Methanol Leaf Extract of C. singueana on Apomorphine-induced Stereotypic Climbing in Mice

C. singueana methanol leaf extract significantly (P < 0.05) decreased the stereotypic climbing induced by apomorphine [Figure 4].

thumblarge

Figure 4: Effect of methanol leaf extract of Cassia singueana on apomorphine-induced stereotypic climbing in mice. HLP: Haloperidol, CSE: C. singueana methanol leaf extract. Data are presented as mean ± standard error of mean; *P < 0.05, n = 6, Dunnett’s post hoc test

Effect of Methanol Leaf Extract of C. singueana on Catalepsy Duration in Mice

C. singueana methanol leaf extract significantly (P < 0.05) increased the duration of catalepsy induced by haloperidol [Figure 5].

thumblarge

Figure 5: Effect of methanol leaf extract of Cassia singueana on catalepsy duration in mice. CSE: C. singueana methanol leaf extract. Data are presented as mean ± standard error of mean; *P < 0.05, n = 6, Dunnett’s post hoc test

DISCUSSION

Plants chemical constituents constitute an indispensable part of medicinal plants and are responsible for their numerous bioactivities C. singueana methanol leaf extract significantly reduced the onset and prolonged the duration of sleep induced by diazepam. This action suggests that the C. singueana methanol leaf extract may possess sedating properties. It has been reported that saponins show significant sedative activity when tested in similar models.[17] Alkaloids are the most important secondary metabolites in many plants that are held responsible for their sedative and anxiolytic action.[18]

This sedative-hypnotic property could be related to the presence of triterpenes. It was previously reported that triterpenes activate benzodiazepines, barbiturates, and/or gamma-aminobutyric acid (GABA) receptors in the GABAA receptor complex.[19]

C. singueana methanol leaf extract significantly increased the number of foot slip by mice in the beam walk assay; increased foot slip indicates motor coordination deficit.[13] A similar finding was also reported by Magaji et al.[20] who noticed a central nervous system depressant effect of a plant by its virtue to cause motor incoordination using beam walk assay.[20] While using a different plant to assay its neurobehavioral effects Magaji et al.[21] also reported no significantly increase in number of foot slips in the beam walking assay, suggesting that the extract used does not possess significant motor coordination deficit and this finding suggests the plant may be devoid of central nervous system depression.[21]

C. singueana methanol leaf extract significantly and dose dependently decreased the number of head dips in the hole-board test, indicating decreased in exploratory behavior. As reported by Wadenberg,[22] the hole-board experiment is a measure of exploratory behavior in animals. A decrease in exploratory behavior indicates central nervous system depressant effect[30] Similarly, Magaji et al.[20] reported that a different plant possesses central nervous system depressant effect by decreasing exploratory behavior of the experimental animals. Furthermore, Adzu has reported a different plant with central nervous system depressant effect to decrease a number of head dips in hole-board test.

C. singueana methanol leaf extract significantly decreased the stereotypic climbing induced by apomorphine. The ability of drug to inhibit apomorphine-induced climbing behavior in mice has been correlated with neuroleptic activity. Inhibition of apomorphine-induced climbing in mouse is suggestive of D1 and D2 receptor blockade. The ability of the extract to antagonize apomorphine-induced climbing behavior supports the hypotheses of central nervous system activity which might be related to antidopaminergic actions on the limbic system as suggested by Anca et al.[23] and Morais et al.[24] A similar finding has been reported by Magaji et al.[20] Furthermore, Sotoing[25] reported a decrease in climbing behavior induced by apomorphine after oral administration of a neuroleptic extract. Amoateng et al. have also observed a significant reduction in the frequencies of apomorphine-induced rearing and cage climbing in mice after oral administration of an extract with possible antipsychotic activity.[26]

C. singueana methanol leaf extract significantly increased the duration of catalepsy induced by haloperidol. Increase or prolongation of haloperidol-induced catalepsy is correlated with neuroleptic activity and possible extrapyramidal side effect. Catalepsy in laboratory animals is defined as a failure to correct an externally imposed posture, and the test entails measuring the latency for the animal to remove itself from the unfamiliar and uncomfortable position. In mice, induction of catalepsy with haloperidol and other selective D2 receptor antagonist shows marked affinity for D2 receptor and predictive value for the identification of drugs liable to induce extrapyramidal side effects in humans. Extrapyramidal side effects are a major side effect that is known to account for the discontinuation of antipsychotic drug use in patients.[28] Ultimately, the current research for new antipsychotic drug discovery is focused on agents with minimal or no extrapyramidal side effects in addition to clinical efficacy.[27,28]

Our result reveals that the extract of C. singueana contains pharmacologically active substance(s) that might be acting centrally through the inhibition of dopaminergic pathway or a system linked to this pathway to mediate the prolongation of the cataleptic duration supported by Pandhare et al.[29]

CONCLUSION

From the data obtained in this research, it can be concluded that, Cassia singueana methanol leaf extrac may contain phytochemicals with antischizophrenic and central nervous system depressant effect.

REFERENCES

1. WHO/PRO. Guidelines for the Appropriate use of Herbal Medicines. 2000. 1-88.

2. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, et al.Schizophrenia: Manifestations, incidence and course in different cultures. A world health organization ten-country study. Psychol Med Monogr Suppl 1992;20:1-97.

3. Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, et al.Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry 2006;63:1079-87.

4. Meltzer HY. Treatment of schizophrenia and spectrum disorders: Pharmacotherapy, psychosocial treatments, and neurotransmitter interactions. Biol Psychiatry 1999;46:1321-7.

5. Ibrahim MA, Koorbanally NA, Islam MS. In vitro anti-oxidative activities and GC-MS analysis of various solvent extracts of Cassia singueana parts. Acta Pol Pharm 2013;70:709-19.

6. Ottu OJ, Atawodi SE, Onyike E. Antioxidant, hepatoprotective and hypolipidemic effects of methanolic root extract of Cassia singueana in rats following acute and chronic carbon tetrachloride intoxication. Asian Pac J Trop Med 2013;6:609-15.

7. Ode OJ, Asuzu OV. Investigation of cassia singueana leaf extract for antiulcer effects using ethanol-induced gastric ulcer model in rats. Int J Plant Anim Environ Sci 2011;1:1-7.

8. Adamu HM, Abeyeh OJ, Ibok NN, Kafu SE. Antifungal activity of extracts of some Cassia, Detarium and Ziziphus species against dermotophyte. Nat Prod Radiance 2006;5:357-60.

9. Beretz A, Haag-Berrurie M, Anton R. Change in the pharmacological activity of medicinal plants. Plant Med Phytother 1978;4:305-14.

10. Rakotonirina VS, Bum EN, Rakotonirina A, Bopelet M. Sedative properties of the decoction of the rhizome of Cyperus articulatus. Fitoterapia 2001;72:22-9.

11. File SE. Effects of chlorpromazine on exploration and habituation in the rat. Br J Pharmacol 1973;49:303-10.

12. Wolfman C, Viola H, Paladini A, Dajas F, Medina JH. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol Biochem Behav 1994;47:1-4.

13. Stanley JL, Lincoln RJ, Brown TA, McDonald LM, Dawson GR, Reynolds DS, et al. The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines. J Psychopharmacol 2005;19:221-7.

14. Protais P, Costentin J, Schwartz JC. Climbing behavior induced by apomorphine in mice: A simple test for the study of dopamine receptors in striatum. Psychopharmacology (Berl) 1976;50:1-6.

15. Costall B, Naylor RJ. On catalepsy and catatonia and the predictability of the cataleptic test for neuroleptics activity. Psychopharmacology 1978;34:233-41.

16. Prinssen EP, Kleven MS, Koek W. The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT1A receptor agonist properties. Eur J Pharmacol 1998;356:189-92.

17. Dubois MA, Ilyas M, Wagnar H. Cussonoides A and B, two triterpenes-saponins from Cussonia barteri. Planta Med 1986;56:80-3.

18. Elisabetsky E, Costa-Campos L. The alkaloid alstonine: A review of its pharmacological properties. Evid Based Complement Alternat Med 2006;3:39-48.

19. Rang HP, Dale MM, Ritter JM, Moore PK, editors. Antiepileptic drugs. In: Pharmacology. 7th ed. London: Churchill Livingstone;2011. p. 540-52.

20. Magaji MG, Anuka JA, Abdu-Aguye I, Yaro AH, Hussaini IM. Behavioural effects of the methanolic root bark extract of Securinega virosa in rodents. Afr J Tradit Complement Altern Med 2008;5:147-53.

21. Magaji MG, Yaro AH, Musa AM, Anuka JA, Abdu-Aguye I, Hussaini IM, et al. Central depressant activity of butanol fraction of Securinega virosa root bark in mice. J Ethnopharmacol 2012;141:128-33.

22. Wadenberg ML, Kapur S, Soliman A, Jones C, Vaccarino F. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology (Berl) 2000;150:422-9.

23. Anca JM, Lamela M, Calleja JM. Activity on the central nervous system of Himanthalia elongata. Planta Med 1993;59:218-20.

24. Morais LC, Barbosa-Filho JM, Almeida RN. Central depressant effects of reticuline extracted from Ocotea duckei in rats and mice. J Ethnopharmacol 1998;62:57-61.

25. Sotoing Taïwe G, Ngo Bum E, Talla E, Dawe A, Okomolo Moto FC, Temkou Ngoupaye G, et al. Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense (Hutch.) milne-redh (Asteraceae) in rodents. J Ethnopharmacol 2012;143:213-20.

26. Amoateng P, Adjei S, Osei-Safo D, Kukuia KK, Bekoe EO, Karikari TK, et al. Extract of Synedrella nodiflora (L) gaertn exhibits antipsychotic properties in murine models of psychosis. BMC Complement Altern Med 2017;17:389.

27. Bricker B, Sampson D, Ablordeppey SY. Evaluation of the potential of antipsychotic agents to induce catalepsy in rats: Assessment of a new, commercially available, semi-automated instrument. Pharmacol Biochem Behav 2014;120:109-16.

28. Aberg K, Adkins DE, Bukszár J, Webb BT, Caroff SN, Miller DD, et al. Genomewide association study of movement-related adverse antipsychotic effects. Biol Psychiatry 2010;67:279-82.

29. Pandhare RB, Mohite PB, Khanage SG, Sangameswaran B. In vivo anticonvulsant activity of Aegle marmelos Corr. J Pharm Res 2009;2:1852-4.

30. Adzu B, Gamaniel K. Sedative effects of Cassia singueana root bark. J Nat Remedies 2003;3:134-7.